Good MorningEquity markets started the week on weakened footing following the start of Trump's tariffs. However, the news isn't all bad. Investors bought the early morning weakness, leaving the S&P 500 well off the session's lows by the day's end. The takeaway is that Trump's tariffs will likely cause market volatility, but the upward trend is intact, and new all-time-high index prices are possible.
Earnings will help drive the action this week. After the Monday close, an after-hours report from Palantir underscored the impact of AI on business, leading its stock to a 15% gain. Other critical reports include Advanced Micro Devices, Amazon, and Google, all expected to report solidly.
Critical economic data is also expected this week. Monthly labor data are due, including the ADP, Challenger, JOLTs, and non-farm payroll reports. The consensus is that the data align with trends, including steady job creation, low unemployment, and rising wages. Featured: The 7 Best Stocks to Own in Summer 2025 (Ad) 
|
Stocks | | |
Starting small is usually good advice when beginning a new endeavor. If you’re trying to get back in shape, a quick run or light workout is a better starting point than a marathon. However, that logic is counterintuitive when it comes to stocks. Bigger stocks tend to be safer and less volati... Read the Full Story |
|
From Our Partners | | Cold War Discovery Could Unlock $100 Trillion in Wealth
Jeff recently traveled to an American ghost town to investigate this crazy Cold War story…
Because it could hold the key to the entire $100 trillion AI boom.
It involves an American ghost town with just 30 people…
And a new twist to the AI boom that could make a lot of people rich. | | Click here to see the details on what could be the biggest tech story of this decade. |
|
Markets | | |
The stock market is going through a historical cycle right now, and most investors aren’t aware of it, given the composition and weighting of the broader S&P 500 and Nasdaq-100 indexes. Considering that these indexes hold mostly stocks inside the technology sector, a concentration of sto... Read the Full Story |
|
Markets | | | Calm returned to Wall Street Tuesday, and tech stocks led U.S. indexes higher following a strong profit report from Palantir Technologies, a darling benefiting from the artificial-intelligence boom.The S&P 500 rose 0.7% a day after swinging sharply on worries that President Donald Trump’s tarif... Read the Full Story |
|
From Our Partners | | It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption.
With Bitcoin hitting $123,000 and giants like BlackRock and Fidelity pouring in, one expert believes a lesser-known coin could soon be vaulted to the top — possibly even landing in the government’s digital reserve. | | See the coin positioned to win from Washington’s crypto push |
|
Markets | | | China has announced retaliatory tariffs on select American imports and an antitrust investigation into Google, just minutes after a sweeping levy on Chinese products imposed by U.S. President Donald Trump took effect Read the Full Story |
|
Markets | | | Companies in a wide range of industries saw their stocks come under pressure Monday on Wall Street because of tariff threats from President Donald Trump.Automakers, technology companies and retailers all fell as the U.S., Mexico, Canada and China wrangled over tariffs. Trump said over the weekend th... Read the Full Story |
|
From Our Partners | | Jeff Brown recently traveled to a ghost town in the middle of an American desert…
To investigate what could be the biggest technology story of this decade.
In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom…
And only one company here in the U.S. can mine this obscure metal. | | Click here to get the details on this virtual monopoly. |
|
Markets | | |
The principle of momentum investing—though contrary to the traditional wisdom of buying low and selling high—suggests that investors can profit by buying rising stocks and selling them before they decline. As a result, momentum is typically favored in short-term and active trading stra... Read the Full Story |
|
Markets | | |
Arguably late to the AI game, Apple’s (NASDAQ: AAPL) understated push into AI has it set up to grow substantially over the next decade. Ultimately, it won’t be about the flashiness of the AI product or launch, but its durability, and Apple has proven to be a durable business. The compa... Read the Full Story |
|
Markets | | | President Donald Trump on Monday signed an executive order directing the U.S. to take steps to start developing a government-owned investment fund that he said could be used to profit off of TikTok if he’s successful at finding the company an American buyer Read the Full Story |
|
Markets | | |
The Wall Street Journal pointed out a peculiar new trend on social media, where influencers are not showcasing their lavish purchases but rather going the opposite route, embracing a “No Buy” trend. Consumers are tired of inflation and lofty credit card interest rates and have deemed 2... Read the Full Story |
|
Markets | | | PepsiCo said Tuesday that high prices and changing consumer tastes have weakened U.S. demand for its snacks and drinks but it's confident it can turn that around in the coming year.The Purchase, New York-based company said its revenue fell slightly to $27.78 billion in the fourth quarter. That was s... Read the Full Story |
|
Tuesday's Early Bird Stock Of The Day CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island. | Should I Buy CVS Health Stock? CVS Bull and Bear Case Explained
These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of CVS Health was last updated on Wednesday, July 09, 2025 at 6:48 PM.
CVS Health Bull Case -
The company reported strong earnings per share of $2.25 for the latest quarter, significantly exceeding analyst expectations, which indicates robust financial performance.
-
CVS Health Co. achieved a revenue of approximately $94.59 billion, surpassing forecasts, showcasing its ability to grow and capture market share.
-
The current stock price is around $75, reflecting a positive market sentiment and potential for further appreciation.
-
Analysts have a consensus rating of "Moderate Buy" for CVS Health Co., with many firms issuing buy ratings, suggesting confidence in the company's future performance.
-
The company has a solid dividend yield of about 3.99%, providing investors with a steady income stream, which is attractive in a low-interest-rate environment.
CVS Health Bear Case -
Despite recent growth, CVS Health Co. has a relatively low net margin of 1.39%, which may indicate challenges in profitability compared to competitors.
-
The company's return on equity stands at 10.59%, which, while positive, may not be as high as some investors would prefer in a competitive market.
-
Insider ownership is only about 1.22%, which could suggest a lack of confidence from those closest to the company regarding its future prospects.
-
CVS Health Co. has a payout ratio of 63.48%, indicating that a significant portion of earnings is being distributed as dividends, which may limit funds available for reinvestment in growth initiatives.
-
Market analysts have varying target prices, with some estimates being significantly lower than the current stock price, indicating potential volatility and uncertainty in future valuations.
| | View Today's Stock Pick |
|
